Search results
Prostate Cancer Screening: What Does Your Patient Fear Most?
Medscape· 6 days agoDr Neil Skolnik distills available recommendations (including recent AUA guidance) to help...
Chemoradiotherapy or RT in Lower Risk Early Cervical Cancer?
Medscape· 6 days agoA study found no significant differences in survival with postoperative chemoradiotherapy vs RT...
Hammerling-Hodgers: Summer is here. Take protective measures to stay safe from sun's rays
Florida Today via Yahoo News· 7 days agoIf there is a mole that you are born with and changes or a new skin lesion appears and does not go...
Mabwell Announces 9MW2821 Clinical Data and Latest Progress to be presented at 2024 ASCO Annual...
FOX 59 Indianapolis· 3 days agoMabwell (688062.SH), an innovation-driven biopharmaceutical company, announced the data and latest...
Regeneron (REGN) Announces Positive Data on Oncology Candidate
Zacks via Yahoo Finance· 3 days agoRegeneron's (REGN) REGN7075, in combination with its oncology drug Libtayo, generates anti-tumor...
KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid...
Nature· 4 days agoInactivated suppressor of mothers against decapentaplegic homolog (SMAD) 4 significantly affects cancer development in pancreatic ductal adenocarcinoma (PDAC). However, the contribution of smad4 ...
Potential Precursor Lesion to Adrenal Tumors Identified
Medscape· 5 days agoCortisol-producing adenomas (CPAs) are preceded by the development of steroids-producing nodules...
Hsa_circ_0007590/PTBP1 complex reprograms glucose metabolism by reducing the stability of...
Nature· 18 hours agoThe role of circular RNAs (circRNAs) in glucose metabolism in pancreatic duct adenocarcinoma (PDAC) remains elusive. Through RNA sequencing of cells cultured under conditions of glucose deprivation ...
These Are The Expert-Approved Ways To Help Prevent Skin Cancer | Essence
Essence· 6 days agoBy now, we know our melanin doesn’t protect us from the sun, thanks to hyperpigmentation, premature...
Nimbus reports positive data from Phase I/II solid tumour therapy trial
Clinical Trials Arena via Yahoo Finance· 4 days agoAccording to the results, 16.7% of response-evaluable patients experienced clinical benefits from...